Two monoclonal antibodies to D-dimer-specific inhibitors of fibrin polymerization

Thrombosis Research

Volumn 113, Issue 3-4, 2004, Pages 251-259

  Lugovskoy, E V ^a   Gritsenko, P G ^a   Kolesnikova, I N ^a   Zolotarova, E N ^a   Chernishov, V I ^a   Nieuwenhuizen, W ^b   Komisarenko, S V ^a  

^a PALLADIN INSTITUTE OF BIOCHEMISTRY   (Ukraine)

^b TNO   (Netherlands)

Author keywords

Fibrin; Monoclonal antibodies; Polymerization inhibitors; Polymerization sites

Indexed keywords

D DIMER; EPITOPE; FIBRIN; FIBRIN MONOMER; GLYCYLPROLYLARGINYLPROLINE; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PEPTIDE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ALPHA CHAIN; ANTIBODY COMBINING SITE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; ELECTRON MICROSCOPY; FIBRIN FORMATION; FIBRIN POLYMERIZATION; HUMAN; HYBRIDOMA; MOLECULE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN IMMOBILIZATION; TERMINAL SEQUENCE;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BIOPOLYMERS; BLOOD COAGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN FAB FRAGMENTS; OLIGOPEPTIDES; PROTEIN STRUCTURE, TERTIARY;

EID: 2342616728     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.03.005     Document Type: Article

References (35)

1. Olexa S.A., Budzynski A.Z. Localization of a fibrin polymerization site. J. Biol. Chem. 256:1981;3544-3549
2. Everse S.J., Spraggon G., Veerapandin L., Riley M., Doolittle R.F. Crystal structure of fragment double-D from human fibrin with two different bound ligands. Biochemistry. 37:1998;8637-8642
3. Fowler W.E., Hantgan R.R., Hermans J., Erickson H.P. Structure of the fibrin protofibril. Proc. Natl. Acad. Sci. U. S. A. 78:1981;4872-4876
4. Hantgan R.R., Hermans J. Assembly of fibrin: a light scattering study. J. Biol. Chem. 254:1979;11272-11280
5. Yang Z., Mochalkin I., Doolittle R.F. A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. Proc. Natl. Acad. Sci. U. S. A. 97:2000;14156-14161
6. Pandya B.V., Cierniewski C.S., Budzynski A.Z. Conservation of human fibrinogen conformation after cleavage of the Bβ-chain amino terminus. J. Biol. Chem. 260:1985;2994-3000
7. Siebenlist K.R., Di Orio J.P., Budzynski A.Z., Mosesson M.N. The polymerization and thrombin-binding properties of des-(Bβ1-42)-fibrin. J. Biol. Chem. 265:1990;18650-18655
8. Moskowitz K.A., Budzynski A.Z. The (DD)E complex is maintained by a composite fibrin polymerization site. Biochemistry. 33:1994;12937-12944
9. Cierniewski C.S., Poniatowski J. The effect of anti-β43-47 Fab fragments of the polymerization sites in the E domain of fibrinogen. Acta Biochim. Pol. 37:1990;31-37
10. Yakovlev S., Makogonenko E., Kurochkina N., Nieuwenhuizen W., Ingham K., Medved L. Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites. Biochemistry. 39:2000;15730-15741
11. Komisarenko S.V. Antigenic determinants of proteins and peptides. Voelter W., Bayer E., Ovchinnikov Y., Ivanov V. Chemistry of Peptides and Proteins. vol. 3:1986;235-247 Walter de Gruyter, Berlin
12. Lugovskoi E.V., Komisarenko S.V. The use of monoclonal antibodies for studying the fibrin polymerization. Russ. J. Bioorgan. Chem. 26(12):2000;791-798
13. Lugovskoy E.V., Kolesnikova I.N., Gritsenko P.G., Zolotareva E.N., Gaffney P., Nieuwenhuizen W., et al. A neoantigenic determinant in the D-dimer fragment of fibrin. Thromb. Res. 107(3-4):2002;151-156
14. Wisloff F., Michaelsen T.E., Godal H.C. Inhibition or acceleration of fibrin polymerization by monoclonal immunoglobulins and immunoglobulin fragments. Thromb. Res. 35:1984;81-90
15. Koppert P.W., Huijsmans C.M.G., Nieuwenhuizen W. A monoclonal antibody, specific for human fibrinogen, fibrinopeptide A-containing fragments and not reacting with free fibrinopeptide A. Blood. 66:1985;503-507
16. Cierniewski C.S., Budzynski A.L. Involvement of the α-chain in fibrin clot formation. Effect of monoclonal antibodies. Biochemistry. 31:1992;4248-4253
17. Cierniewski C.S., Janiak A., Wiroba E. Modification of fibrin network ultrastructure by Fab fragments specific for different domains of fibrinogen. Acta Biochim. Pol. 33:1986;195-202
18. Wasser M.N., Welling M., Lamers G., Pauwels E.K., Nieuwenhuizen W.A. Effect of an antifibrin monoclonal antibody and fragments thereof on some properties of fibrin. Thromb. Haemost. 63:1990;39-43
19. Lugovskoi E.V., Makogonenko E.M., Chudnovets S.G., Derzskaya S.G., Gogolinskaya G.K., Kolesnikova I.N., et al. The study of fibrin polymerization with monoclonal antibodies. Biomed. Sci. 2:1991;249-256
20. Lugovskoi E.V., Makogonenko E.M., Chudnovets V.S., et al. Investigation of fibrin polymerization with monoclonal antibodies 2d-2a and their Fab-fragments. Ukr. Biochim. Z. 1:1995;64-71
21. Varetskaya T.V. Microheterogeneity of fibrinogen. Cryofibrinogen. Ukr. Biokhim. Z. 32:1960;13-24. [in Ukrainian]
22. Belitser V.A., Varetskaja T.V., Malneva G.V. Fibrinogen-fibrin interaction. Biochim. Biophys. Acta. 154:1968;376
23. Lougovskoi E.V., Gogolinskaya G.R. Preparation of fibrin desAA by thrombin. Ukr. Biokhim. Z. 71:1999;107-108
24. Marder V.J., Budzynski A.Z., Barlow G.H. Comparison of the physiochemical properties of fragment D derivatives of fibrinogen and fragment DD of cross-linked fibrin. Biochim. Biophys. Acta. 427:1976;1-14
25. Belitzer V.A., Pozdniakova T.M., Ugarova T.P. Light and heavy fractions of fragment D: preparation and examination of fibrin-binding properties. Thromb. Res. 19:1980;807-814
26. Medved L.V., Novohatni V.V., Privalov P.L. The preparation and investigation of the structure organization of the active and nonactive form of D fragment of fibrinogen molecule. Mol. Biol. 16:1982;1195-1202
27. Medved L.V., Privalov P.L., Ugarova T.P. Isolation of thermostable structure from the fibrinogen D fragment. FEBS Lett. 146:1982;339-342
28. Schägger H., von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:1987;368-379
29. Tsang V.C.W., Peralta J.M., Simons A.R. Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis. Methods Enzymol. 92:1983;377-391
30. Timpl R., Gollwitzer R. Cyanogen bromide cleavage of bovine fibrinogen. Identification of a dimeric N-terminal peptide and two other disulfide containing fragments. FEBS Lett. 29:1973;92-96
31. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256:1975;495-497
32. Friquet B., Alain F., Chaffte F., Djavadi-Ohaniance L., Goldberg M.E. Measurement of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J. Immunol. Methods. 77:1985;305-319
33. Hantgan R., Fowler W., Erickson H., Hermans J. Fibrin assembly: a comparison of electron microscopic and light scattering result. Thromb. Haemost. 44:1980;119-124
34. Laudano A.P., Doolittle R.F. Influence of calcium ion on the binding of fibrin amino terminal peptides to fibrinogen. Science. 212:1981;457-459
35. Everse S.J., Spraggon G., Veerapandian L., Doolittle R.F. Conformational changes in fragments D and double-D from human fibrin(ogen) upon binding the peptide ligand Gly-His-Arg-Pro-amide. Biochemistry. 38:1999;2941-2946